These findings suggest that liraglutide plays a protective role in the kidney of DN rats by decreasing the blood glucose/lipid levels and expression of miR-34, HIF-1a, Egr-1, and TGF-β1 while increasing the SIRT1 levels. This evidence concerns the gene SIRT1 and liver dysplastic nodule.